ArticleBMJ case reports2016

Single-eye trial of a topical carbonic anhydrase inhibitor versus intravitreal bevacizumab for the treatment of taxane drug-induced cystoid macula oedema.

Mark M Hassall et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.